Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps

Launched by KATRINA ATEF HABASHY · Jun 10, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to study chronic rhinosinusitis with nasal polyps (CRSwNP), a condition that causes inflammation in the nasal passages and can lead to nasal polyps, which are growths in the nose. The main goal of the study is to find out which factors can predict how well patients respond to treatment with oral corticosteroids, a type of medication often used to reduce inflammation.

To participate in the trial, you would need to have a clinical diagnosis of CRSwNP. However, if you have taken any steroids, antihistamines, or other immune-modulating medications in the past four weeks, or if you have had previous nasal or sinus surgery, certain types of fungal sinus conditions, or other specific issues, you may not be eligible. The trial is not yet recruiting participants, so it's important to stay informed if you or a loved one is interested in taking part. If eligible, participants can expect to provide information about their condition and response to medications, which will help researchers better understand how to treat this challenging condition in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • clinical diagnosis of chronic rhinosinusitis with nasal polyps
• Exclusion Criteria:
• • 1-Patients who had taken any steroid , antihistamine or other immune-modulating medications within the past 4 weeks
• • 2- previous nasal and sinus surgery.
• • 3-Allergic Fungal rhinosinusitis.
• • 4-Unilateral rhinosinusitis.
• • 5- Antrochoanal polyps or cystic fibrosis.